Revisions of 'Non-ischaemic cerebral enhancing (NICE) lesions'
-
Revision 7 - major - created 4 months ago by Rohit Sharma ◉ - view changesetDate: 2024-11-26 18:39:57 UTC Disclosures:
At the time the revision was created Rohit Sharma had no financial relationships to ineligible companies to disclose.
View Rohit Sharma's current disclosures Reviewed by: Joachim Feger -
Revision 6 - major - created 4 months ago by Daniel Pielenz ◉ - view changesetDate: 2024-11-26 14:06:58 UTC Disclosures:
At the time the revision was created Daniel Pielenz had no financial relationships to ineligible companies to disclose.
View Daniel Pielenz's current disclosures Reviewed by: Rohit Sharma -
Revision 5 - major - created 10 months ago by Rohit Sharma ◉ - view changesetDate: 2024-05-27 22:26:34 UTC Disclosures:
At the time the revision was created Rohit Sharma had no financial relationships to ineligible companies to disclose.
View Rohit Sharma's current disclosures Reviewed by: Yuranga Weerakkody -
Revision 4 - major - created 10 months ago by Rohit Sharma ◉ - view changesetDate: 2024-05-27 09:35:59 UTC Disclosures:
At the time the revision was created Rohit Sharma had no financial relationships to ineligible companies to disclose.
View Rohit Sharma's current disclosures Reviewed by: Joachim Feger -
Revision 3 - major - created over 2 years ago by Bálint Botz - view changesetDate: 2022-11-29 13:58:59 UTC Disclosures:
At the time the revision was created Bálint Botz had no financial relationships to ineligible companies to disclose.
View Bálint Botz's current disclosures Reviewed by: Sonam Vadera -
Revision 2 - major - created over 2 years ago by Frank Gaillard ◉ ◈ - view changesetDate: 2022-11-27 04:48:16 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Yahya Baba -
Revision 1 - major - created over 2 years ago by Frank Gaillard ◉ ◈ - view changesetDate: 2022-11-27 04:16:02 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Bálint Botz
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.